Strength
100 mg/mL
Manufacturer
Janssen Biotech, Inc.NDC
57894007102
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/2/2026
Active Ingredients
GOLIMUMABApproval Type
Biologic (BLA)
FDA Application
BLA125289On Market Since
5/15/2013
Pharmacological Classes
Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
REMICADE 100 MG VIAL
Brand
57894003001•Janssen Biotech, Inc.
$1135.9660
per EA
ENBREL 25 MG/0.5 ML SYRINGE
Brand
58406001004•Immunex Corporation
$2076.2308
per ML
ENBREL 50 MG/ML SYRINGE
Brand
58406002104•Immunex Corporation
$2080.7423
per ML
ENBREL 50 MG/ML MINI CARTRIDGE
Brand
58406004404•Immunex Corporation
$2081.5847
per ML
ENBREL 50 MG/ML SURECLICK
Brand
58406003204•Immunex Corporation
$2083.3498
per ML
CIMZIA 2X200 MG/ML(X3)START KT
Brand
50474071081•UCB, Inc.
$6072.5137
per EA
CIMZIA 2X200 MG/ML SYRINGE KIT
Brand
50474071079•UCB, Inc.
$6112.3912
per EA